These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Theophylline-associated status epilepticus in an infant: pharmacokinetics and the risk of suppository use. Kato Z; Yamagishi A; Nakamura M; Kondo N World J Pediatr; 2009 Nov; 5(4):316-8. PubMed ID: 19911151 [TBL] [Abstract][Full Text] [Related]
5. Novel chronotherapeutic rectal aminophylline delivery system for therapy of asthma. Shiohira H; Fujii M; Koizumi N; Kondoh M; Watanabe Y Int J Pharm; 2009 Sep; 379(1):119-24. PubMed ID: 19555748 [TBL] [Abstract][Full Text] [Related]
10. [How safe are dimenhydrinate suppositories?]. Bernhard MK; Mütze U; Syrbe S Dtsch Med Wochenschr; 2013 Oct; 138(42):2143-5. PubMed ID: 24104589 [TBL] [Abstract][Full Text] [Related]
11. [Biopharmaceutical evaluation of aminophylline suppositories. II. Biological availability of aminophylline (theophylline) from suppositories with normal and prolonged time of total deformation]. Masiakowski J; Cieszyński T; Dyderski S; Perz A Acta Pol Pharm; 1984; 41(1):105-10. PubMed ID: 6496133 [No Abstract] [Full Text] [Related]
12. [Biopharmaceutical evaluation of aminophylline suppositories. I. Pharmacological parameters of theophylline from aminophylline suppositories with normal and prolonged time of total deformation]. Masiakowski J; Cieszyński T; Dyderski S; Perz A Acta Pol Pharm; 1984; 41(1):99-104. PubMed ID: 6496143 [No Abstract] [Full Text] [Related]
13. Pulsed proton NMR and solid-liquid fat ratio determinations in suppository vehicles and aminophylline suppositories. De Blaey CJ; Varkevisser FA; Kalk A Pharm Weekbl Sci; 1984 Oct; 6(5):203-8. PubMed ID: 6504688 [TBL] [Abstract][Full Text] [Related]
14. Severe toxic effects from aminophylline and theophylline suppositories in children. NOLKE AC J Am Med Assoc; 1956 Jun; 161(8):693-7. PubMed ID: 13318989 [No Abstract] [Full Text] [Related]
15. Lipovac v Black: was Dr Black negligent? Gerber P Med J Aust; 1999 Jun; 170(11):550-2. PubMed ID: 10397048 [No Abstract] [Full Text] [Related]
16. New labeling for aminophylline rectal suppositories. FDA Drug Bull; 1980 Nov; 10(3):24. PubMed ID: 7450337 [No Abstract] [Full Text] [Related]
17. Decomposition of aminophylline in suppository formulations. Brower JF; Juenge EC; Page DP; Dow ML J Pharm Sci; 1980 Aug; 69(8):942-5. PubMed ID: 7400941 [TBL] [Abstract][Full Text] [Related]
18. Release and rectal absorption of aminophylline suppositories prepared in a hospital pharmacy. Fujii T; Kubota A; Mizushima N Tokai J Exp Clin Med; 1982 Sep; 7(5):539-46. PubMed ID: 7182946 [TBL] [Abstract][Full Text] [Related]
19. Two aminophylline preparations in nocturnal asthma. Al-Khader A; Cole RB; Thompson D Br J Dis Chest; 1979 Apr; 73(2):169-72. PubMed ID: 394755 [TBL] [Abstract][Full Text] [Related]
20. Aminophylline with a barbiturate as a rectal suppository in the treatment of asthma. FRANKLIN HL N Y State J Med; 1947 Jun; 47(11):1242. PubMed ID: 20241275 [No Abstract] [Full Text] [Related] [Next] [New Search]